Summary

The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 8.43% during 2025-2033. The global market is primarily driven by their enhanced therapeutic efficacy, advancements in PEGylation technologies, and the rising global prevalence of chronic diseases, fueling robust investments in biopharmaceuticals that offer improved treatment outcomes and sustained drug performance.

PEGylated proteins are biomolecules that have been modified by covalent conjugation with polyethylene glycol (PEG). It involves the PEGylation technique that improves the pharmacokinetic behavior of the medicine by altering the biological molecule's physical and chemical characteristics, such as its conformation, electrostatic binding, and hydrophobicity. PEGylated proteins are widely used in therapeutic applications, such as vaccines, hormone replacement therapy, genetic disorders, anemia, and blood clotting disorder. It is also used in various drugs for diseases, including kidney disease, multiple sclerosis, hemophilia, and cancers. PEGylated proteins help in the extension of half-life, increasing stability, solubility, and proteolytic protection, reducing renal excretion, immunogenicity, and toxicity, and enhancing the efficacy of drug delivery. Besides this, PEGylated proteins are non-toxic, water-soluble, hydrophilic, non-antigenic, and non-immunogenic.

PEGylated Proteins Market Trends:
The rising prevalence of chronic diseases, such as kidney ailments, autoimmune diseases, genetic disorders, hepatitis, and rheumatoid arthritis across the globe is one of the key factors driving the market growth. PEGylated proteins are widely used to treat inflammation, deliver corrective genes to cells, prevent blood clots, deliver growth hormones, and prevent the progression of chronic kidney disease. In line with this, the widespread product utilization in cancer treatment to deliver chemotherapy drugs directly to cancer cells and reduce the side effects on healthy cells is favoring the market growth. Apart from this, various improvements in the PEGylation technology, such as the development of new PEGylation methods that can produce smaller and more complex molecules, are providing an impetus to the market growth. Additionally, the widespread adoption of PEGylation to improve the stability and half-life of colony-stimulating factors (CSFs), making them more effective as therapeutic agents, is acting as another growth-inducing factor. Furthermore, the rising adoption of protein-based drugs over non-protein-based drugs wherein PEGylation increases the circulation and half-life of the proteins, improving its efficiency, is propelling the market growth. Other factors, including the increasing number of product approvals for PEGylated proteins, development in the field of biotechnology and molecular biology engineering, the integration of PEG molecules in biopharmaceuticals and the associated advantages, rising geriatric population, and the implementation of various government initiatives to increase regulatory standards in the pharmaceutical industry, are anticipated drive the market further toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global PEGylated proteins market, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on product, protein type, application, and end user.

Product Insights:

Consumables
PEGylation Reagents
PEGylation Kits
Services

A detailed breakup and analysis of the PEGylated proteins market based on the product has also been provided in the report. This includes consumables (PEgylation reagents and PEgylation kits) and services. According to the report, consumables accounted for the largest market share.

Protein Type Insights:

Colony Stimulating Factors
Interferons
Erythropoietin
mAbs
Recombinant Factor VII
Others

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the protein type. This includes colony stimulating factors, interferons, erythropoietin, mAbs, recombinant factor VII and others. According to the report, colony stimulating factors represented the largest segment.

Application Insights:

Cancer Treatment
Hepatitis
Chronic Kidney Diseases
Hemophilia
Multiple Sclerosis
Gastrointestinal Disorders
Others

A detailed breakup and analysis of the PEGylated proteins market based on the application has also been provided in the report. This includes cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and others. According to the report, cancer treatment represented the largest segment.

End User Insights:

Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the end user. This includes pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for PEGylated proteins. Some of the factors driving the North America PEGylated proteins market included the rising geriatric population, increasing prevalence of chronic diseases, and extensive research and development (R&D).

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global PEGylated proteins market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

1. How big is the global PEGylated proteins market?
2. What is the expected growth rate of the global PEGylated proteins market during 2025-2033?
3. What are the key factors driving the global PEGylated proteins market?
4. What has been the impact of COVID-19 on the global PEGylated proteins market?
5. What is the breakup of the global PEGylated proteins market based on the product?
6. What is the breakup of the global PEGylated proteins market based on the protein type?
7. What is the breakup of the global PEGylated proteins market based on the application?
8. What is the breakup of the global PEGylated proteins market based on the end user?
9. What are the key regions in the global PEGylated proteins market?
10. Who are the key players/companies in the global PEGylated proteins market?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global PEGylated Proteins Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 PEGylation Reagents
6.1.2.2 PEGylation Kits
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Protein Type
7.1 Colony Stimulating Factors
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Interferons
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Erythropoietin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 mAbs
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Recombinant Factor VII
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Cancer Treatment
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hepatitis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Chronic Kidney Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hemophilia
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Multiple Sclerosis
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Gastrointestinal Disorders
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Contract Research Organizations
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic and Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abcam plc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biomatrik Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Creative PEGWorks
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Iris Biotech GmbH
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 JenKem Technology USA Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Laysan Bio Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 NOF America Corporation (NOF Corporation)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Profacgen
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Thermo Fisher Scientific Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2024
Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2024
Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2024
Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2024
Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2024
Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: China: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: India: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: France: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2024
Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million USD), 2025-2033
Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: PEGylated Proteins Market: Competitive Structure
Table 8: Global: PEGylated Proteins Market: Key Players